Researchers hunt for clues to prevent dangerous clots in rare blood cancer
NCT ID NCT05548062
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watches 242 adults with high-risk polycythemia vera (a rare blood cancer that thickens the blood) who have already had a blood clot. Researchers track health data like blood pressure, weight, and lab tests to see which factors best predict future clots. The goal is to help doctors identify who is most at risk and improve prevention strategies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Alessandria, AL, 15121, Italy
-
Novartis Investigative Site
Ancona, AN, 60126, Italy
-
Novartis Investigative Site
Bari, BA, 70124, Italy
-
Novartis Investigative Site
Bologna, BO, 40138, Italy
-
Novartis Investigative Site
Como, CO, 22100, Italy
-
Novartis Investigative Site
Cosenza, CS, 87100, Italy
-
Novartis Investigative Site
Catania, CT, 95123, Italy
-
Novartis Investigative Site
Florence, FI, 50134, Italy
-
Novartis Investigative Site
Genova, GE, 16132, Italy
-
Novartis Investigative Site
Lecce, LE, 73100, Italy
-
Novartis Investigative Site
Tricase, LE, 73039, Italy
-
Novartis Investigative Site
Monza, MB, 20900, Italy
-
Novartis Investigative Site
Milan, MI, 20122, Italy
-
Novartis Investigative Site
Palermo, PA, 90127, Italy
-
Novartis Investigative Site
Palermo, PA, 90146, Italy
-
Novartis Investigative Site
Piacenza, PC, 29121, Italy
-
Novartis Investigative Site
Padova, PD, 35128, Italy
-
Novartis Investigative Site
Pisa, PI, 56126, Italy
-
Novartis Investigative Site
Parma, PR, 43126, Italy
-
Novartis Investigative Site
Reggio Calabria, RC, 89124, Italy
-
Novartis Investigative Site
Reggio Emilia, RE, 42123, Italy
-
Novartis Investigative Site
Roma, RM, 00161, Italy
-
Novartis Investigative Site
Roma, RM, 00168, Italy
-
Novartis Investigative Site
Roma, RM, 00189, Italy
-
Novartis Investigative Site
Pagani, SA, 84016, Italy
-
Novartis Investigative Site
Orbassano, TO, 10043, Italy
-
Novartis Investigative Site
Torino, TO, 10126, Italy
-
Novartis Investigative Site
Terni, TR, 05100, Italy
-
Novartis Investigative Site
Varese, VA, 21100, Italy
-
Novartis Investigative Site
Vicenza, VI, 36100, Italy
-
Novartis Investigative Site
Verona, VR, 37134, Italy
-
Novartis Investigative Site
Viterbo, VT, 01033, Italy
-
Novartis Investigative Site
Naples, 80131, Italy